Information Provided By:
Fly News Breaks for November 23, 2015
MRTX
Nov 23, 2015 | 07:15 EDT
Citi analyst Yigal Nochomovitz started Mirati Therapeutics with a Neutral rating and $43 price target.
News For MRTX From the Last 2 Days
There are no results for your query MRTX